Navigation Links
TetraQ and Q-Pharm form strategic alliance
Date:6/16/2008

"TetraQ has a strong track record in fully-validated bioanalytical method development and sample analysis and we are recognised leaders in this area," Professor Smith said.

"TetraQ's GLP recognition and NATA ISO 17025 (R&D) accreditation has positioned TetraQ as the leading integrated preclinical service provider to the Australian biopharmaceutical industry. Q-Pharm is an industry leader in Phase 1 clinical trials so the alliance offers a consistent and reliable level of service."

The alliance was negotiated with the support of UniQuest Pty Limited, UQ's main commercialisation company.

UniQuest was also responsible for setting up TetraQ as the commercial arm of the Centre for Integrated Preclinical Drug Development at UQ and Q-Pharm as a joint venture with the Queensland Institute of Medical Research.

With their world-recognized credentials, both TetraQ and Q-Pharm have established enviable reputations for high quality services. Both organisations are committed to operating within quality frameworks that comply with the relevant industry-related international standards.

TetraQ was established in 2005 as the first contract research organization in Australia to provide integrated preclinical services to the global pharmaceutical and biotechnology industries. Its state-of-the-art facilities and equipment meet stringent quality and testing standards, and its bioanalytical work is accepted internationally for regulatory review, providing clients in the pharmaceutical and biotechnology industries with a high degree of assurance.

Emerging from UQ's Centre for Studies in Drug Disposition, Q-Pharm Pty Limited has grown rapidly in the past six years to become a major provider of Phase 1 clinical trial services to national and international clients. It also conducts Phase I clinical trials, pharmacokinetic studies and bioequivalence studies from its state-of-the-art facilities within the Royal Brisbane and Women
'/>"/>

Contact: Rose-Marie Pennisi
61-733-467-374
Research Australia
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. TetraQ recognized for toxicology services
2. National Pharmaceutical Council Announces New Strategic Focus, Search for New Leadership
3. Martopia(R) Forms Strategic Alliance With Modern Healthcare Magazine
4. LehmanMillet Continues Expansion with Strategic Hires
5. Stille and Enova Form Strategic Partnership to Introduce Worlds Brightest LED Cordless Surgical Headlights Into Europe and Japan
6. Benjamin England, Former FDA Regulatory Counsel, to Testify on FDA Import Strategic Plan Before House Appropriations Subcommittee
7. Diet.com Enters Strategic Collaboration To Support Microsoft HealthVault
8. Lumenis Ltd. Announces Senior Leadership Appointments Strengthening the Companys Strategic Businesses
9. Avantium and BP Extend Strategic Partnership
10. 40 86 Strategic Income Fund Declares Dividend
11. Medco, LabCorp Strike Strategic Agreement for Research on Personalized Medicine and Pharmacogenomics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... ... August 03, 2015 , ... A July 9 article ... emergency rooms in recent years, according to the American Dental Association. According to a ... emergency visits went from 1.1 million in a single year to 2.2 million a ...
(Date:8/3/2015)... (PRWEB) , ... August 03, 2015 , ... ... is predicted to decline by 39 percent, according to market research compiled for ... includes data from the U.S. Department of Labor, Bureau of Labor Statistics. As ...
(Date:8/3/2015)... ... August 03, 2015 , ... Dignity Health named Dr. Norris A. Baldwin, ... Room – Gilbert, opening in August. The new facility is licensed under ... Valley. , “Dr. Baldwin is an excellent leader and will ensure our new ...
(Date:8/3/2015)... ... ... Constantin Vasilica, 48 from Romania wanted to have an alternative healing doctor for ... suffering and using medications with strong side effects. This had already forced him to ... or wait longer hours in the waiting rooms. Instead, he went home at the ...
(Date:8/3/2015)... (PRWEB) , ... August 03, 2015 , ... Foot ... of a new associate podiatrist, creating the largest medical practice in the Mid-Atlantic region ... ankle medicine. FASMA operates 21 locations with 33 doctors. , Dr. Hetal Kathrotiya-Mago is ...
Breaking Medicine News(10 mins):Health News:Los Angeles Periodontists Comment on Rising Dental Emergency Room Trips 2Health News:Los Angeles Periodontists Comment on Rising Dental Emergency Room Trips 3Health News:Dental Association Announces Impending Reduction of Dental Laboratories Could Impact Dentists 2Health News:Dental Association Announces Impending Reduction of Dental Laboratories Could Impact Dentists 3Health News:Dignity Health Names Dr. Norris A. Baldwin, Jr. Facility Medical Director of New Freestanding Emergency Room 2Health News:Dignity Health Names Dr. Norris A. Baldwin, Jr. Facility Medical Director of New Freestanding Emergency Room 3Health News:Chinese Health Care Provider Heshoutang Now Give Patients Complimentary Online Healing Options 2Health News:Chinese Health Care Provider Heshoutang Now Give Patients Complimentary Online Healing Options 3Health News:Leading Foot and Ankle Medical Practice Adds Three New Podiatrists 2Health News:Leading Foot and Ankle Medical Practice Adds Three New Podiatrists 3Health News:Leading Foot and Ankle Medical Practice Adds Three New Podiatrists 4
... of 27-29 Percent over ... 2007 First-Quarter Year-Over-Year Highlights (adjusted for January 2008 ... two-for-one stock split): - GAAP diluted ... $0.52, excluding $0.05 in amortization of intangible assets from ...
... Aspirin-like compounds (salicylates) can claim another health benefit: ... healthy obese people. Obesity is associated with insulin ... , Aspirin and other salicylates are known ... research accepted for publication in the Journal of ...
... Serious Financial Burden Caused By Medical,Bills; 7 Percent Say ... Spouse Could Get Health Benefits, MENLO PARK, Calif., ... personal economic problems, and their,struggles to deal with those ... health care, a new Kaiser Family Foundation,poll finds., ...
... 30 at 2 p.m. Eastern -, FREMONT, Calif., ... molecular diagnostics company, will host a roundtable,teleconference to address ... and to provide information about the Company,s PAD,blood test, ... place on Wednesday, April 30 at 2 p.m. ET, ...
... to earlier return to work, analysis finds , , MONDAY, ... disease by surgically implanting an artificial vertebrae onto one,s ... fusion operation, but it saves the patient almost $6,000 ... , The cost savings is primarily from the patient,s ...
... Inc. has received a,Small Business Innovative Research ... to continue the testing and development of ... throughput assay system. The,pioneering research performed by ... that allow the rapid development of revolutionary,insect ...
Cached Medicine News:Health News:Medco Reports Strong First-Quarter Results; Record EPS, Mail-Order Volume, Generic Dispensing Rates 2Health News:Medco Reports Strong First-Quarter Results; Record EPS, Mail-Order Volume, Generic Dispensing Rates 3Health News:Medco Reports Strong First-Quarter Results; Record EPS, Mail-Order Volume, Generic Dispensing Rates 4Health News:Medco Reports Strong First-Quarter Results; Record EPS, Mail-Order Volume, Generic Dispensing Rates 5Health News:Medco Reports Strong First-Quarter Results; Record EPS, Mail-Order Volume, Generic Dispensing Rates 6Health News:Medco Reports Strong First-Quarter Results; Record EPS, Mail-Order Volume, Generic Dispensing Rates 7Health News:Medco Reports Strong First-Quarter Results; Record EPS, Mail-Order Volume, Generic Dispensing Rates 8Health News:Medco Reports Strong First-Quarter Results; Record EPS, Mail-Order Volume, Generic Dispensing Rates 9Health News:Medco Reports Strong First-Quarter Results; Record EPS, Mail-Order Volume, Generic Dispensing Rates 10Health News:Medco Reports Strong First-Quarter Results; Record EPS, Mail-Order Volume, Generic Dispensing Rates 11Health News:Medco Reports Strong First-Quarter Results; Record EPS, Mail-Order Volume, Generic Dispensing Rates 12Health News:Medco Reports Strong First-Quarter Results; Record EPS, Mail-Order Volume, Generic Dispensing Rates 13Health News:Medco Reports Strong First-Quarter Results; Record EPS, Mail-Order Volume, Generic Dispensing Rates 14Health News:Medco Reports Strong First-Quarter Results; Record EPS, Mail-Order Volume, Generic Dispensing Rates 15Health News:Medco Reports Strong First-Quarter Results; Record EPS, Mail-Order Volume, Generic Dispensing Rates 16Health News:Medco Reports Strong First-Quarter Results; Record EPS, Mail-Order Volume, Generic Dispensing Rates 17Health News:Medco Reports Strong First-Quarter Results; Record EPS, Mail-Order Volume, Generic Dispensing Rates 18Health News:Medco Reports Strong First-Quarter Results; Record EPS, Mail-Order Volume, Generic Dispensing Rates 19Health News:Medco Reports Strong First-Quarter Results; Record EPS, Mail-Order Volume, Generic Dispensing Rates 20Health News:Medco Reports Strong First-Quarter Results; Record EPS, Mail-Order Volume, Generic Dispensing Rates 21Health News:Medco Reports Strong First-Quarter Results; Record EPS, Mail-Order Volume, Generic Dispensing Rates 22Health News:Medco Reports Strong First-Quarter Results; Record EPS, Mail-Order Volume, Generic Dispensing Rates 23Health News:Medco Reports Strong First-Quarter Results; Record EPS, Mail-Order Volume, Generic Dispensing Rates 24Health News:Medco Reports Strong First-Quarter Results; Record EPS, Mail-Order Volume, Generic Dispensing Rates 25Health News:Aspirin-like compounds increase insulin secretion in otherwise healthy obese people 2Health News:Americans Rank Health Care Near the Top of Their Economic Woes, New Poll Finds 2Health News:Americans Rank Health Care Near the Top of Their Economic Woes, New Poll Finds 3Health News:Vermillion to Host Live Roundtable Discussion With Lead Investigator of its Peripheral Artery Disease Diagnostic Test Program 2Health News:Vermillion to Host Live Roundtable Discussion With Lead Investigator of its Peripheral Artery Disease Diagnostic Test Program 3Health News:Vermillion to Host Live Roundtable Discussion With Lead Investigator of its Peripheral Artery Disease Diagnostic Test Program 4Health News:Artificial Cervical Disc Surgery Cheaper Than Fusion 2Health News:Inscent, Inc. Receives Federal Grant to Develop Honeybee Repellents 2
(Date:8/3/2015)... , Aug. 3, 2015  Celsion Corporation ... Company will host a conference call to discuss ... an update on its development programs for ThermoDox®, ... two newly acquired technology platforms, TheraPlas™ and TheraSilence™, ... EDT on Monday, August 10, 2015. To participate ...
(Date:8/3/2015)... 2015  EnteroMedics Inc. (NASDAQ: ETRM ), the developer ... metabolic diseases and other gastrointestinal disorders, today announced that ... the Board of Directors, effective July 31, 2015.  Ms. ... the 2018 annual meeting or until her successor is ... in an executive capacity in the healthcare industry for ...
(Date:8/2/2015)... Aug. 3, 2015  Lexicon Pharmaceuticals, Inc. (Nasdaq: ... TELESTAR Phase 3 clinical trial met its primary ... in treating cancer patients with carcinoid syndrome that ... of care. Telotristat etiprate was discovered using Lexicon,s ... is the company,s first discovery to complete a ...
Breaking Medicine Technology:Celsion Corporation to Hold Second Quarter 2015 Financial Results Conference Call on Monday, August 10, 2015 2EnteroMedics Announces Appointment of Lori C. McDougal to the Board of Directors 2EnteroMedics Announces Appointment of Lori C. McDougal to the Board of Directors 3Lexicon Pharmaceuticals Reports Positive Top-Line Results For Pivotal Phase 3 Telotristat Etiprate Study In Cancer Patients With Carcinoid Syndrome 2Lexicon Pharmaceuticals Reports Positive Top-Line Results For Pivotal Phase 3 Telotristat Etiprate Study In Cancer Patients With Carcinoid Syndrome 3Lexicon Pharmaceuticals Reports Positive Top-Line Results For Pivotal Phase 3 Telotristat Etiprate Study In Cancer Patients With Carcinoid Syndrome 4Lexicon Pharmaceuticals Reports Positive Top-Line Results For Pivotal Phase 3 Telotristat Etiprate Study In Cancer Patients With Carcinoid Syndrome 5Lexicon Pharmaceuticals Reports Positive Top-Line Results For Pivotal Phase 3 Telotristat Etiprate Study In Cancer Patients With Carcinoid Syndrome 6
... April 16, 2012 genae, a leading Contract ... industries, today announced that Catalina Trana, MD, has been appointed ... responsible for all clinical, safety and risk management related to ... Catalina, whose extensive clinical and research expertise will be of ...
... subsidiary of Eisai Inc., announced today that it has ... and efficacy of MORAb-004 in the treatment of metastatic ... MORAb-004 is a monoclonal antibody that specifically binds to ... is a randomized, double-blind, placebo-controlled study to assess the ...
Cached Medicine Technology:genae Appoints Chief Medical Officer 2Morphotek®, Inc. Announces Initiation of MORAb-004 Phase 2 Study in Metastatic Colorectal Cancer 2Morphotek®, Inc. Announces Initiation of MORAb-004 Phase 2 Study in Metastatic Colorectal Cancer 3
... Finnpipette Focus from Thermo Labsystems ... ergonomics with uncompromising performance. ... offers a custom fit for ... shorter tip cones allow easier ...
... fixed pipette is ideal for ... volume. Fixed volume FInnpipettes offer ... as other Finnpipette Digital pipettes: ... blow-out (1-40ul), Soft-touch tip ejection, ...
... includes fixed-volume, adjustable-volume, and multichannel models ... Research pro Pipette. Designed with a ... pipettes have earned a worldwide reputation ... with original Eppendorf pipette tips, they ...
... Reference Series 2000 Pipette is a synonym ... compact and robust design, and superior operating ... to operate the measuring stroke and blow-out ... features:Eppendorf "pipette/tip" system ensures utmost accuracy and ...
Medicine Products: